A Phase II Study of Vaginal Testosterone Cream vs. [versus] the Estring [estradiol] for Vaginal Dryness or Decreased Libido in Early Breast Cancer Patients Treated With Aromatase Inhibitors.

Next Previous
Trial Profile

A Phase II Study of Vaginal Testosterone Cream vs. [versus] the Estring [estradiol] for Vaginal Dryness or Decreased Libido in Early Breast Cancer Patients Treated With Aromatase Inhibitors.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Estradiol; Testosterone
  • Indications Atrophic vaginitis; Female sexual dysfunction
  • Focus Adverse reactions
  • Acronyms E-String

    • Most Recent Events

    • 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2012 Planned end date changed from 1 Feb 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov record.
    • 06 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top